PGNY - Progyny Inc Stock Price, Fair Value and News

29.14USD+0.54 (+1.89%)Market Closed

Market Summary

USD29.14+0.54

Market Closed

1.89%

PGNY Alerts

1 major insider sales recently.

PGNY Stock Price

View Fullscreen

PGNY RSI Chart

PGNY Valuation

Market Cap

2.8B

Price/Earnings (Trailing)

45.3

Price/Sales (Trailing)

2.5

EV/EBITDA

32.26

Price/Free Cashflow

14.58

PGNY Price/Sales (Trailing)

PGNY Profitability

EBT Margin

6.94%

Return on Equity

10.72%

Return on Assets

7.71%

Free Cashflow Yield

6.86%

PGNY Fundamentals

PGNY Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

7.62%

Rev. Growth (Qtr)

3.01%

PGNY Earnings

Earnings (TTM)

61.3M

Earnings Growth (Yr)

-4.41%

Earnings Growth (Qtr)

25.45%

Breaking Down PGNY Revenue

Last 7 days

4.9%

Last 30 days

5.8%

Last 90 days

-9.0%

Trailing 12 Months

-26.1%

How does PGNY drawdown profile look like?

PGNY Financial Health

Current Ratio

3.31

PGNY Investor Care

Shares Dilution (1Y)

0.86%

Diluted EPS (TTM)

0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.1B	0	0	0
2023	873.1M	957.5M	1.0B	1.1B
2022	550.7M	617.1M	700.1M	786.9M
2021	386.0M	450.0M	473.4M	500.6M
2020	263.5M	271.9M	309.7M	344.9M
2019	130.3M	160.3M	193.7M	229.7M
2018	62.8M	77.0M	91.2M	105.4M
2017	0	0	0	48.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

CEO	Mr. Peter Anevski
WEBSITE	progyny.com
INDUSTRY	Healthcare Plans
EMPLOYEES	393

Progyny Inc Frequently Asked Questions

What is the ticker symbol for Progyny Inc? What does PGNY stand for in stocks?

PGNY is the stock ticker symbol of Progyny Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Progyny Inc (PGNY)?

As of Fri Jul 26 2024, market cap of Progyny Inc is 2.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PGNY stock?

You can check PGNY's fair value in chart for subscribers.

Is Progyny Inc a good stock to buy?

The fair value guage provides a quick view whether PGNY is over valued or under valued. Whether Progyny Inc is cheap or expensive depends on the assumptions which impact Progyny Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PGNY.

What is Progyny Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, PGNY's PE ratio (Price to Earnings) is 45.3 and Price to Sales (PS) ratio is 2.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PGNY PE ratio will change depending on the future growth rate expectations of investors.